Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Ziyad AlAly

Ozempic Is Now Fighting America's Addiction Crisis — A Massive VA Study Covering 600,000 Veterans Is Rewriting What We Know About Substance Abuse

Drugs like Ozempic and Wegovy — already reshaping obesity treatment — may also slash overdose deaths, ER visits, and alcohol dependence, according to the largest study ever conducted on GLP-1s and addiction.

Medical Daily

Stopping GLP-1s can reverse cardiovascular benefits within six months, study finds

Discontinuing the drugs leaves a ‘lasting scar,’ researchers at WashU Medicine say

The Independent UK

GLP-1s could help curb substance abuse – including alcohol and opioids, new study finds

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Weight-loss jabs linked to reduced risk of 42 conditions including dementia

Psychotic disorders also among conditions found less likely when people with diabetes took medications found in jabs

The Guardian - UK

Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind

A large new study has shed light on the wider health impacts of taking Ozempic-style drugs.

LiveScience

Huge Ozempic and GLP-1 drug study finds they may lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 receptor agonists.

Fortune

COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds

'You may have forgotten that you had COVID years ago, but it has not forgotten about you.'

Fortune

Read news from The Economist, FT, and more,
with one subscription

Long COVID is still a problem, racking up a global cost of $1 trillion

Experts want government agencies to act.

Fortune

COVID's impact lingers even after 3 years post infection, a new study has found

A level of information has been unlocked with the new research indicating that the impact of the Covid-19 virus goes well beyond the initial infection, demonstrating the long-lasting impact the pandemic has had on world health. According to an investigation that was published in Nature Medicine, people can still have…

The Times of India

COVID can cause new health problems even 3 years after infection, study finds. 'We don’t know what’s going to happen at 10 years'

A new report reinforces that the virus is not going away.

Fortune

Long COVID patients confront Congress

Millions have been devastated by long COVID. Experts say it needs to be an urgent government priority

Salon

Doctors Discover People Can Catch ‘long Flu’ Just Like Long COVID

People hospitalized with the flu can suffer long-term, negative health effects – especially relating to their lungs and airways.

Zenger

'Long-Flu': People Hospitalized With Seasonal Influenza May Suffer Negative Health Effects Similar To Long-COVID

The study showed that patients hospitalized with flu or COVID-19 had an increased risk of death, hospital readmission and issues to multiple organs in the months following the infection.

Medical Daily

COVID-19 v. Flu: A ‘much more serious threat,’ new study into long-term risks concludes

‘We trivialize COVID infections at our peril,’ says the author of the study.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

'Long flu' is real, and we've likely 'ignored it for a long time'

Both COVID-19 and the flu can come with a long-term, heightened risk of death, hospital readmission and health issues affecting multiple organ systems.

The Guardian - UK

‘Long flu’: study finds flu patients at higher risk of longer-term illness

Like Covid, flu carries significant risk of ongoing disability and disease, researchers say

WEKU

Pain, fatigue, fuzzy thinking: How long COVID disrupts the brain

The neurological symptoms of COVID can persist for years after an infection. Scientists are just beginning to understand why.

The Conversation

Long COVID symptoms can improve, but their resolution is slow and imperfect

Around 5–10% of people who get infected with SARS-CoV-2 will experience symptoms that persist way beyond the initial acute period, a clinical syndrome we are learning more about, known widely as long COVID.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Long COVID. Shorter Life? New research reveals an arduous road to recovery

The first study to look at two years of data shows the devastating effects of long COVID-but there are still no validated treatments.

The Independent UK

COVID-19 took a toll on heart health and doctors are still grappling with how to help

COVID-19 has taken a toll on the nation's heart health but how profound is only starting to emerge

Tribune News Service

COVID kills 1 person every 4 minutes as vaccine rates fall

After more than three years, the global COVID-19 emergency is officially over. Yet it’s still killing at least one person every four minutes and questions on how to deal with the virus remain unanswered, putting vulnerable people and undervaccinated countries at risk.

WEKU

You're less likely to get long COVID after a second infection than a first

The chances of developing lingering symptoms after COVID appears to fall sharply from the first to the second time someone gets sick, new research finds. The risk is still significant.

Tribune News Service

COVID-19 is still deadlier for patients than flu

COVID-19 isn’t “just a flu,” with a study of hospital patients finding that the virus was still 60% deadlier than influenza last winter.

The Guardian - US

Does Covid reinfection bring more health risks – or make you ‘super immune’?

The debate over the risks of reinfections – which are likely to continue – could determine what precautions people take, but experts disagree on the data

ABC News

As some experts and long-COVID sufferers call for antivirals to be more accessible, others say the science isn't proven yet

Some long COVID sufferers are paying thousands of dollars for COVID-19 antivirals, hoping they will lessen their symptoms during reinfections. While some experts say it's time to allow more Australia access to subsidised medications, others say more research is needed.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Washington University

63 stories

American Heart Association

the Medical Research Future Fund

26 stories

PBAC

13 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.